Supervisory board

Tadd Wessel - Chair

Tadd Wessel - Chair

Less information More information

Tadd Wessel is the Founder and Managing Partner of Petrichor, a private equity firm focused on the healthcare sector. Tadd was formerly a Managing Director at OrbiMed Advisors and Vice President at Fortress Investment Group. Tadd sits on numerous boards of directors of life sciences companies. He holds an A.B. in Biology from Princeton University.

Dr. Andreas Rummelt

Dr. Andreas Rummelt

Less information More information

Dr. Andreas Rummelt is Partner and CEO of InterPharmaLink AG, a Management Consulting firm in Basel, Switzerland. His international career in pharmaceuticals has focused on the areas of manufacturing, quality, technical development and generics and he has served more than twenty years in executive management positions in the industry. From 2004 to 2008, Dr. Rummelt was CEO of Sandoz in Vienna and Holzkirchen. He also served as Group Head of Quality Assurance and Technical Operations at Novartis, a position he held from 2008 until 2010, and he had been a member of the Executive Committee of Novartis from 2006 until his resignation in 2010. Dr. Rummelt is a pharmacist and holds a Ph.D. degree from the University of Erlangen-Nuremberg.

Dr. Maximilian Rittmeister

Dr. Maximilian Rittmeister

Less information More information

Dr. Maximilian Rittmeister is a corporate lawyer and managing shareholder of a German corporate law firm. He holds a Ph.D. degree in M&A law from Johann Wolfgang von Goethe – University in Frankfurt/Main, Germany. Dr. Rittmeister is a member of several supervisory and advisory boards and also acts as a private equity investor. He is married, has two sons, and lives near Frankfurt/Main, Germany.

Dr. Jean-Paul Prieels

Dr. Jean-Paul Prieels

Less information More information

Jaul-Paul Prieels holds a PhD in Biochemistry from Université Libre de Bruxelles in Belgium. After ten years at university, he started his industrial career at Petrofina in 1983 as Biotechnology Manager and joined GlaxoSmithKline Biologicals in 1987. His responsibilities gradually expanded to lead the vaccine preclinical R&D development activities in Rixensart, Belgium, and he retired as Senior Vice President of Research & Development in 2011. He was instrumental in the development of several commercially available vaccines, such as Rotarix, Cervarix and Synflorix. Today, he is Director at various companies and member of the Scientific Advisory Board of Singapore Bioprocessing Technology Institute and MolMed SPA. He is also a member of the European Vaccine Initiative Board of Stakeholders.

Dr. Wolfgang Schwandner

Dr. Wolfgang Schwandner

Less information More information

Dr. Wolfgang Schwandner is a business angel and investor in several health care and life science companies. He is founder of various pharmaceutical and health care companies focusing on generic manufacturing, wholesaling and service, and has more than 20 years of experience in executive positions in the international pharmaceutical industry. He holds a diploma and a PhD degree in Biology from Ludwig-Maximilians-Universität and Technische Universität München. Wolfgang is married, has two daughters and lives near Munich.

Dr. Gerhard Ries

Dr. Gerhard Ries

Less information More information

Dr. Gerhard Ries is Managing Partner of LifeCare Partners, a dedicated venture capital and private equity firm in the European healthcare sector. Gerhard has more than 20 years of global pharma industry and venture capital experience as both entrepreneur and investor. He supervised more than 50 investments in life science companies and served on the board of more than 20 companies. Gerhard has a strong scientific and operational background and held various corporate positions at McKinsey, Novartis, Ciba Geigy and Boehringer Mannheim and was co-founder and Managing Partner of BioMedPartners. Gerhard holds a M.S. and a Ph.D. degree in Molecular Biology from the University of Basel as well as a M.Sc. degree in Biotechnology from the Fachhochschule Weihenstephan.